Brian T. Feeley, MD, FAAOS, was bestowed with the 2025 Kappa Delta Elizabeth Winston Lanier Award for his research in advancing the understanding of muscle degeneration in rotator cuff injuries and ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A new spinal cord implant may help people with spinal muscular atrophy (SMA) regain some muscle function, giving the ...

Describe how imaging and the use of new therapies for geographic atrophy secondary to age-related macular degeneration can fit into the treatment paradigm. Summarize innovations in imaging that ...

What is SPINRAZA and its current approval status? SPINRAZA is an approved treatment for spinal muscular atrophy in over 71 countries, currently delivered at a dose of 12 mg. Disclaimer ...

but post-treatment orthostatic hypotension did not change significantly. Imaging studies have shown brain and cerebellar atrophy. The mechanisms leading to IVIG-induced BP elevation are unclear.

less muscle atrophy and less weakness over time. This study stems from preclinical work carried out by Professor Richard Robitaille at l’Université de Montréal (UdeM), during which the treatment ...